Nerve growth factor gene therapy reverses age-related degeneration of cholinergic innervation

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1282, 2001-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on photodynamic therapy in age-related macular degeneration

By Rechtman Ehud Ciulla Thomas A Criswell Mark H Pollack Ayala Harris Alon

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 931-938

Informa Healthcare

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor: A Promising Strategy for Treating Age-Related Macular Degeneration

By Waisbourd Michael Loewenstein Anat Goldstein Michaella Leibovitch Igal

Drugs & Aging, Vol. 24, Iss. 8, 2007-01 ,pp. : 643-662

Adis International

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

A new era in the treatment of age-related macular degeneration: from Factor X to antiangiogenesis

By Gamulescu Maria-Andreea Helbig Horst

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1351-1363

Informa Healthcare

Access to resources Recommend Favorite

CFH and LOC387715/ARMS2 genotypes and antioxidants and zinc therapy for age-related macular degeneration

By Lee Aaron Y Brantley Jr Milam A

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1547-1550

Future Medicine

Access to resources Recommend Favorite